1. Home
  2. |Insights
  3. |Third Circuit Holds that MA organizations have a direct right of recovery under the Medicare Secondary Payer (MSP) Act

Third Circuit Holds that MA organizations have a direct right of recovery under the Medicare Secondary Payer (MSP) Act

Client Alert | 2 min read | 06.28.12

The Third Circuit has held that Medicare Advantage organizations (MAOs) have a direct right of recovery against primary payers under the Medicare Secondary Payer (MSP) Act. The Third Circuit decision arises out of a lawsuit brought by Humana, Inc., as an MAO, to recover for medical expenses paid by Humana on behalf of Medicare beneficiaries related to the use of Avandia, a drug marketed by GlaxoSmithKline (GSK). The decision is In re: Avandia Marketing, Sales Practices and Products Liability Litigation, GlaxoSmithKline, LLC, No. 11-2664 (3rd Cir. June 28, 2012).

The court held specifically that the MSP provision in 42 U.S.C. § 1395y(b)(3)(A), provides MAOs with a private cause of action against primary payers. The court's decision is based on the plain text of Section 1395y(b)(3)(A), which establishes "a private cause of action for damages (which shall be in an amount double the amount otherwise provided) in the case of a primary plan which fails to provide for primary payment (or appropriate reimbursement) in accordance with [the requirements of the MSP Act]."

The court held that the plain text of this provision "sweeps broadly enough to include MAOs," such that MAOs are proper plaintiffs to recover under the terms of the statutory provisions. The court also noted that even if it had determined the statute to be ambiguous on this point, it would have deferred to CMS regulations stating that MAOs have the same right to recover as the Medicare Trust Fund does under the MSP Act.

As the court noted, prior cases in which MAOs had unsuccessfully sought a federal cause of action were not premised on 42 U.S.C. § 1395y(b)(3)(A), but on specific Medicare Advantage provisions of the Medicare Act. The court held that these prior cases were largely irrelevant to deciding the issue before it. The decision gives MAOs an important new tool for attempting to recover from primary payers for Medicare covered expenses, in addition to being able to continue using subrogation and other related legal remedies.

Crowell & Moring attorneys Art Lerner, Barbara Ryland and Amy Tridgell submitted an amicus brief on behalf of America's Health Insurance Plans in support of Humana's position.

 

Insights

Client Alert | 6 min read | 03.26.24

California Office of Health Care Affordability Notice Requirement for Material Change Transactions Closing on or After April 1, 2024

Starting next week, on April 1st, health care entities in California closing “material change transactions” will be required to notify California’s new Office of Health Care Affordability (“OHCA”) and potentially undergo an extensive review process prior to closing. The new review process will impact a broad range of providers, payers, delivery systems, and pharmacy benefit managers with either a current California footprint or a plan to expand into the California market. While health care service plans in California are already subject to an extensive transaction approval process by the Department of Managed Health Care, other health care entities in California have not been required to file notices of transactions historically, and so the notice requirement will have a significant impact on how health care entities need to structure and close deals in California, and the timing on which closing is permitted to occur....